Cargando…
Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19
SARS-CoV-2, the causative agent of COVID-19, remains among the main causes of global mortality. Although antigen/antibody-based immunoassays and neutralizing antibodies targeting SARS-CoV-2 have been successfully developed over the past 2 years, they are often inefficient and unreliable for emerging...
Autores principales: | Zhang, Yang, Juhas, Mario, Kwok, Chun Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340053/ https://www.ncbi.nlm.nih.gov/pubmed/35995601 http://dx.doi.org/10.1016/j.tibtech.2022.07.012 |
Ejemplares similares
-
The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19
por: Geurts, Maarten H., et al.
Publicado: (2021) -
Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era
por: Dzuvor, Christian K. O., et al.
Publicado: (2022) -
Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma
por: Kłos, Patrycja, et al.
Publicado: (2022) -
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
por: Jahan, Sheikh Tasnim, et al.
Publicado: (2017) -
Promising new tools to fight Aedes mosquitoes
Publicado: (2016)